Skip to content
Parakho

Asarfi Hospital Ltd

BSE 543943asarfihospital.com

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with BSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ crore—vs a year ago6M FY26
Revenue from operations——91.89
Other income——1.36
Total income——93.26
Employee benefit expense——14.34
Finance costs——1.96
Depreciation & amortisation——5.60
Total expenses——80.68
Profit before tax——12.58
Tax expense——3.00
Profit after tax——9.58
Total comprehensive income———
Earnings per share
Earnings per share, basic—₹4.87
Earnings per share, diluted—₹4.87

6M FY26 — from the company’s filing with BSE. Source

Why the dash

Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.

Earnings call

Q4 FY26

Asarfi Hospital reported consolidated FY26 revenue growth of 42% year-on-year to INR173.5 crores, with EBITDA up 42% to INR35.3 crores and PAT up 58% to INR16.7 crores. Q4 FY26 consolidated revenue grew 29% year-on-year to INR45.2 crores, with EBITDA of INR7.7 crores and PAT of INR3.9 crores. Management discussed capacity expansion in cardiology and cancer care, delays in bone marrow transplant approval and a proposed hospital merger, and outlined a Vision 2028 target of INR400 crores revenue with 500-plus beds.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Filings

12 shown · 30 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Hospital

Classification as published by BSE.

Companies also in Hospital, in alphabetical order

All 34 companies in Hospital

Page generated from filings held to 08 Oct 2026.